Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Ansell et al reported considerable variations in policies
concerning the use of prophylactic vitamin K in the United Kingdom.1 With the published data supporting and not
refuting the association of neonatal vitamin K with childhood
malignancies,
2 3
the current practice of several policies
is of serious concern. A lack of consensus was also shown in a national
survey we conducted in the Republic of Ireland.
Relevant information was collected by using a questionnaire from all the 23 maternity units, and the range of practices was compared. Dose, frequency, route, and time of vitamin K prophylaxis in breastfed and bottlefed infants among term and preterm categories was determined. The survey was sent to the sister or midwife in charge of the labour ward and neonatal unit of each hospital during February and March 2001.
All 23 maternity units in the eight health boards responded to the
survey, giving a 100% response rate.